Altimmune (ALT) Non Operating Income (2010 - 2026)
Altimmune (ALT) reported Non Operating Income of -$152000.0 for Q1 2026, down 1113.33% year-over-year from $15000.0 in Q1 2025, and down 462.96% quarter-over-quarter from -$27000.0 in Q4 2025.
Altimmune (ALT) Non Operating Income (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Non Operating Income data on file, last reported at -$152000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$152000.0, down 1113.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 134.84% YoY), and the FY2025 annual result was -$190000.0, down 495.83% from the prior year.
- Non Operating Income fell to -$152000.0 in Q1 2026 per ALT's latest filing, from -$27000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.9 million in Q2 2023 and troughed at -$6.4 million in Q4 2024.
- A 5-year average of -$168411.8 and a median of $15000.0 in 2025 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 7684.0% in 2023 and fell as far as 2358.06% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$217000.0 in 2022, then slumped by 2358.06% to -$5.3 million in 2023, then decreased by 19.59% to -$6.4 million in 2024, then surged by 99.58% to -$27000.0 in 2025, then plunged by 462.96% to -$152000.0 in 2026.
- Business Quant data shows ALT's Non Operating Income at -$152000.0 in Q1 2026, -$27000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | -152,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -152,000.00 |
| Dec 31, 2025 | -27,000.00 |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | -92,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | -6.38 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | -76,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | -5.33 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 1.69 Mn |
| Dec 31, 2022 | -217,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 69,000.00 |
| Dec 31, 2021 | -81,000.00 |
| Sep 30, 2021 | -306,000.00 |
| Jun 30, 2021 | 37,000.00 |